| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1399-0039.1997.TB02827.X |
| P698 | PubMed publication ID | 9243749 |
| P50 | author | Steven G. E. Marsh | Q7615026 |
| Caroline Sabin | Q42249738 | ||
| P2093 | author name string | J A Madrigal | |
| J N Zuckerman | |||
| A B McDermott | |||
| P2860 | cites work | Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen | Q41616784 |
| Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens. | Q43518589 | ||
| P433 | issue | 1 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 8-14 | |
| P577 | publication date | 1997-07-01 | |
| P1433 | published in | Tissue Antigens | Q1573131 |
| P1476 | title | Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination | |
| P478 | volume | 50 |
| Q90040182 | A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals |
| Q28299722 | A comparative review of HLA associations with hepatitis B and C viral infections across global populations |
| Q34189153 | A prophylactic hepatitis B vaccine with a novel adjuvant system |
| Q37057737 | Anti-HBs Cellular Immune Response in Kidney Recipients before and 4 Months after Transplantation |
| Q40778973 | Antibody responses to preS components after immunization of children with low doses of BioHepB. |
| Q45723479 | Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity. |
| Q33905171 | Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population |
| Q78164018 | Association of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection |
| Q33845532 | Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B. |
| Q50945882 | Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. |
| Q34247198 | CD3Z genetic polymorphism in immune response to hepatitis B vaccination in two independent Chinese populations |
| Q40820460 | Celiac disease and viral B hepatitis: lessons for clinical practice. |
| Q40836583 | Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines |
| Q37407229 | Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. |
| Q36890020 | Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection |
| Q44072943 | Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. |
| Q47901561 | Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites |
| Q44128216 | Does HLA type predispose some individuals to cancer? |
| Q92008619 | Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother-to-child transmission of hepatitis B virus |
| Q38261395 | Ex vivo assessment of cellular immune function - applications in patient care and clinical studies |
| Q92339205 | Factors That Influence the Immune Response to Vaccination |
| Q61045098 | Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus |
| Q23910391 | Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations |
| Q37444410 | HLA and infectious diseases |
| Q51964512 | HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. |
| Q73798271 | HLA class II alleles in Chinese patients with hepatocellular carcinoma |
| Q28207155 | HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies |
| Q52684468 | HLA-B*07, HLA-DRB1*07, HLA-DRB1*12, and HLA-C*03:02 Strongly Associate With BMI: Data From 1.3 Million Healthy Chinese Adults. |
| Q44066657 | HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy |
| Q50852226 | Hepatitis B third-generation vaccines: improved response and conventional vaccine non-response--evidence for genetic basis in humans. |
| Q53862563 | High-dose hepatitis B vaccine in patients waiting for lung transplantation. |
| Q30322079 | Host genes and infectious diseases. HIV, other pathogens, and a public health perspective. |
| Q33325499 | Host genetic factors and vaccine-induced immunity to hepatitis B virus infection |
| Q104073833 | Host genetics and infectious disease: new tools, insights and translational opportunities |
| Q36383797 | Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines |
| Q78164075 | Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine |
| Q46046973 | Hydrogel-Delivered GM-CSF Overcomes Nonresponsiveness to Hepatitis B Vaccine through the Recruitment and Activation of Dendritic Cells |
| Q49045963 | Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvant |
| Q35215767 | Immunogenetics of the response to HBsAg vaccination |
| Q44781098 | Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine |
| Q36922684 | Immunologic hypo- or non-responder in natural dengue virus infection |
| Q61045104 | Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children |
| Q40605429 | MHC typing in variant Creutzfeldt-Jakob disease. |
| Q40417522 | Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness |
| Q28276283 | New genetic associations detected in a host response study to hepatitis B vaccine |
| Q92842980 | Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination |
| Q40447718 | Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation. |
| Q34545711 | Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen |
| Q35193410 | Recombinant hepatitis B triple antigen vaccine: Hepacare |
| Q43821525 | Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents |
| Q44263762 | Role of HLA allele polymorphism in chronic hepatitis B virus infection and HBV vaccine sensitivity in patients from eastern Turkey |
| Q27007034 | Searching for the human genetic factors standing in the way of universally effective vaccines |
| Q38124198 | The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis |
| Q78424586 | The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population |
| Q24812950 | Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors |
Search more.